Breaking News Instant updates and real-time market news.

PD

PagerDuty

$26.10

-0.495 (-1.86%)

, SFIX

Stitch Fix

$20.77

-0.09 (-0.43%)

08:45
10/11/19
10/11
08:45
10/11/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: PagerDuty (PD) 91.63% +24.03, Stitch Fix (SFIX) 30.13% +1.04, ADT (ADT) 13.92% +0.78, Beyond Meat (BYND) 187.61% +0.46, Tanger Factory (SKT) 5.04% +0.41, McDermott (MDR) 10.04% +0.28, NIO (NIO) 43.00% +0.26, United States Oil Fund (USO) 1.32% +0.17, California Resources (CRC) 1.54% +0.12, and Intercept (ICPT) 0.47% +0.11.

PD

PagerDuty

$26.10

-0.495 (-1.86%)

SFIX

Stitch Fix

$20.77

-0.09 (-0.43%)

ADT

ADT Inc.

$6.40

0.14 (2.24%)

BYND

Beyond Meat

$136.00

-3.17 (-2.28%)

SKT

Tanger Factory

$14.50

0.14 (0.97%)

MDR

McDermott

$1.95

0.2 (11.43%)

NIO

NIO Inc.

$1.53

-0.105 (-6.44%)

USO

United States Oil Fund

$11.20

0.215 (1.96%)

CRC

California Resources

$8.54

0.17 (2.03%)

ICPT

Intercept

$58.92

1.55 (2.70%)

  • 22

    Oct

  • 31

    Oct

  • 04

    Nov

  • 12

    Nov

  • 12

    Nov

PD PagerDuty
$26.10

-0.495 (-1.86%)

09/06/19
MSCO
09/06/19
NO CHANGE
Target $43
MSCO
Equal Weight
PagerDuty FY20 guidance may be 'less than hoped for,' says Morgan Stanley
Morgan Stanley analyst Sanjit Singh said he sees "a lot to like" in PagerDuty's Q2 report, including faster billings growth and an uptick in large customers, but noted that its FY20 guidance implies slower growth in the second half and "may be less than hoped for." Singh, who thinks guidance reflects prudent conservatism, but also reflects some caution on the pace of new product adoption, keeps an Equal Weight rating on PagerDuty shares and lowered his price target to $43 from $47.
10/02/19
RHCO
10/02/19
INITIATION
RHCO
Hold
PagerDuty initiated with a Hold at SunTrust
SunTrust analyst Joel Fishbein initiated PagerDuty with a Hold rating and $32 price target.
08/28/19
MSCO
08/28/19
NO CHANGE
Target $48
MSCO
Equal Weight
PagerDuty estimates remain conservative, says Morgan Stanley
Morgan Stanley analyst Sanjit Singh kept his Equal Weight rating and the base case price target on PagerDuty (PD) at $48 as part of a broader research note into select software names. The analyst notes that even though the company beat on Q1 revenue and billings, the stock price declined 30% since the company last reported results, likely driven by the upcoming lock-up expiration on October 8th and the greater competitive environment coming price cuts at Atlassian (TEAM) and Splunk (SPLK). Singh contends however that the competitive dynamics will not yet show up in PagerDuty's Q2 results and believes that the management's guidance for FY20 is "highly conservative".
10/02/19
RHCO
10/02/19
INITIATION
RHCO
SunTrust initiates infrastructure and security sector
SunTrust analyst Joel Fishbein initiated fourteen stocks in the infrastructure and security sector. Regarding infrastructure, he said he believes "we are in the 3rd inning of a multi year (even multi-decade) opportunity" and projected on-demand penetration of 70% by 2028, adding that "spending on cloud software is projected to grow at ~3x the overall software market rate, resulting in a greater than $208B market opportunity through 2025." However, Fishbein cautioned to "stay selective" as while he is bullish on the underlying trends, "too many investors are chasing too few stories." For cybersecurity, Fishbein noted that it remains a top priority for the corporations, and cited the IDC stating that "worldwide spending on security-related hardware, software, and services is forecast to reach $133.7B in 2022 at a compound annual growth rate of 9.9%." He believes that emerging vendors with innovative technology are growing much faster, and sees a "shift in spending from legacy security providers to next generation technology providers and multi-product platforms." The analyst started eight names with Buy ratings -- Atlassian (TEAM), New Relic (NEWR), ServiceNow (NOW), Splunk (SPLK), Palo Alto Networks (PANW), Rapid7 (RPD), SailPoint (SAIL), and Zscaler (ZS). The other six names Fishbein started with Hold ratings -- PagerDuty (PD), Check Point (CHKP), FireEye (FEYE), Proofpoint (PFPT), Qualys (QLYS), and Tenable Holdings (TENB).
SFIX Stitch Fix
$20.77

-0.09 (-0.43%)

10/02/19
WELS
10/02/19
NO CHANGE
Target $20
WELS
Market Perform
Stitch Fix price target lowered to $20 from $30 at Wells Fargo
Wells Fargo analyst Ike Boruchow lowered his price target for Stitch Fix to $20 from $30 following "somewhat disappointing" Q4 results. More importantly, while top-line guidance continues to call for 20%-plus growth, the outlook for profitability is more concerning, he contends. The analyst reiterates a Market Perform rating on the shares.
10/02/19
RBCM
10/02/19
NO CHANGE
Target $38
RBCM
Outperform
Stitch Fix price target lowered to $38 from $43 at RBC Capital
RBC Capital analyst Mark Mahaney lowered his price target on Stitch Fix to $38 after its "mixed" Q4 results. The analyst notes that while revenue and active client growth was in line with expectations, gross margins and EBITDA missed because of "increased Inventory & Data Science spend". Mahaney adds that the management's revenue forecasts bracketed consensus, but EBITDA outlook was "materially below" expectations. The analyst still keeps his Outperform rating on Stitch Fix and believes that its "intriguing" Direct-Buy functionality could be a "game-changer" in terms of client spend and client retention.
10/02/19
JPMS
10/02/19
NO CHANGE
Target $24
JPMS
Neutral
Stitch Fix price target lowered to $24 from $34 at JPMorgan
JPMorgan analyst Doug Anmuth lowered his price target for Stitch Fix to $24 from $34 and keeps a Neutral rating on the shares following last night's fiscal Q4 results. The analyst expects the company's margins to compress for a fifth year in a row in fiscal 2020, and he believes its sales outlook sets a high bar as it assumes a notable revenue acceleration through the quarters.
10/08/19
STFL
10/08/19
NO CHANGE
Target $28
STFL
Buy
Stifel maintains favorable view of Stitch Fix after 'better than feared' Q4
Stifel analyst Scott Devitt said that despite the fact that some investors have expressed concerns over Stitch Fix's Q1 and FY20 profitability guidance, he thinks the company's Q4 results were "better than feared," he believes the company is right to invest to expand the platform and enhance the user experience and he sees a number of tailwinds for its longer-term growth. Devitt reiterated his Buy rating and $28 price target on Stitch Fix shares.
ADT ADT Inc.
$6.40

0.14 (2.24%)

03/12/19
SBSH
03/12/19
DOWNGRADE
Target $8.25
SBSH
Neutral
ADT Inc. downgraded to Neutral from Buy at Citi
Cit downgraded ADT Inc. to Neutral from Buy and lowered its price target for the shares to $8.25 from $13. The firm sees a less certain free cash flow trajectory following ADT's Q4 results.
03/15/19
IMPC
03/15/19
NO CHANGE
Target $12
IMPC
Outperform
ADT Inc. price target lowered to $12 from $15 at Imperial Capital
Imperial Capital analyst Jeff Kessler lowered his price target for ADT Inc. to $12 from $15 saying "heavy" investment translated to reduced free cash flow guidance for 2019. The analyst, however, sees continued revenue growth for ADT and maintains an Outperform rating on the shares.
05/13/19
05/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) and Titan Machinery (TITN) downgraded to Neutral from Outperform at Baird. 2. Boot Barn (BOOT) downgraded to Hold from Buy at Pivotal Research with analyst Mitch Kummetz saying he sees a less favorable risk/reward at current share levels heading into the company's results on May 16. He does not see enough room for upside to his estimates, mainly because he believes oil and gas employment is becoming a "diminishing tailwind." 3. Shopify (SHOP) downgraded to Neutral from Buy at Guggenheim with analyst Ken Wong saying he sees upside potential as limited given the stock's current valuation, which he notes has now passed previous peak levels. 4. ADT Inc. (ADT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Toni Kaplan saying she has less confidence in the company's growth outlook following a recent AlphaWise survey conducted by the firm. 5. 51job (JOBS) downgraded to Neutral from Buy at Citi with analyst Alicia Yap saying she believes weakening operating metrics, such as a faster rate of decline for active employer count and slower rate of growth of ARPU, may be signals of challenges for online recruitment revenue growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/13/19
MSCO
05/13/19
DOWNGRADE
Target $7
MSCO
Equal Weight
ADT Inc. downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Toni Kaplan downgraded ADT Inc. (ADT) to Equal Weight from Overweight as she has less confidence in the company's growth outlook following a recent AlphaWise survey conducted by the firm. The survey showed homeowners seem as inclined to buy DIY systems as ADT systems, that more ADT customers switched to DIY providers than she would have expected and that measure of brand preference for Amazon's (AMZN) Ring and Google's (GOOG) Nest were higher than for ADT, Kaplan explains. Given that the survey leads her to fear ADT may find it difficult to defend its market share, Kaplan lowered her price target on the stock to $7 from $9.
BYND Beyond Meat
$136.00

-3.17 (-2.28%)

09/26/19
SPHN
09/26/19
NO CHANGE
Target $230
SPHN
Overweight
Stephens doesn't see 'full blown' alternative beef rollout at McDonald's in U.S.
After McDonald's (MCD) announced plans for a 12-week test in Canada of a new plant-based burger using a Beyond Meat (BYND) patty, Stephens analyst Will Slabaugh said he is happy to see the burger giant consider an entry into the plant-based market. However, he is not expecting a near-term "full blown" alternative beef rollout in the U.S., primarily due to supply chain reasons. He views an alternative chicken product as more likely for a nation-wide launch in 2020/2021 in the U.S. in conjunction with exclusive poultry provider Tyson (TSN). He also thinks a chicken product would likely be "more novel" and a larger sales driver, said Slabaugh, who keeps an Overweight rating and $230 price target on McDonald's shares.
09/26/19
JEFF
09/26/19
NO CHANGE
Target $190
JEFF
Hold
Beyond Meat to 'squeeze sharply higher' after McDonald's news, says Jefferies
Jefferies analyst Kevin Grundy said McDonald's (MCD) interest in Beyond Meat (BYND) makes sense for both sides and the announcement of a trial by the burger giant "is what bulls have been waiting for" given McDonald's 38,000 worldwide locations. With short interest near 50% of float, he would expect Beyond Meat shares to "squeeze sharply higher," Grundy tells investors. If McDonald's were to pursue a broader roll-out in the U.S. of the "PLT" burgers, it could add greater than 40% to his current FY20 sales forecast on a run-rate basis, added Grundy, who keeps a Hold rating on Beyond Meat shares, citing valuation.
09/26/19
WBLR
09/26/19
NO CHANGE
WBLR
Market Perform
William Blair encouraged, but not surprised, by McDonald's testing Beyond Meat
William Blair analyst Jon Andersen is not surprised by the announcement that McDonald's (MCD) will conduct a 12-week test in Canada of a plant-based burger made with patties from Beyond Meat (BYND). However, the analyst is encouraged by Beyond Meat's involvement, pointing out that many major burger chains have added plant-based options amid rising consumer interest and demand, and better product technology. This includes Carl's Jr. Beyond Famous Star burger, Burger King's new Impossible Whopper, and White Castle's Impossible slider, Andersen points out in a research note. He keeps a Market Perform rating on Beyond Meat, whose stock is up 13%, or $18.28, to $156.60 in early trading.
09/23/19
EXAN
09/23/19
INITIATION
EXAN
Underperform
Beyond Meat initiated with an Underperform at Exane BNP Paribas
SKT Tanger Factory
$14.50

0.14 (0.97%)

10/16/18
SCOT
10/16/18
INITIATION
Target $21
SCOT
Underperform
Tanger Factory initiated with an Underperform at Scotiabank
Scotiabank analyst Nicholas Yulico initiated Tanger Factory with an Underperform and $21 price target.
12/19/18
JPMS
12/19/18
DOWNGRADE
Target $22
JPMS
Underweight
Tanger Factory downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Anthony Paolone downgraded Tanger Factory to Underweight and lowered his price target for the shares to $22 from $24. The downgrade is primarily driven by an improved outlook/preference for other property types in the REIT space, says the analyst.
03/25/19
BOSC
03/25/19
INITIATION
Target $27
BOSC
Outperform
Tanger Factory initiated with an Outperform at Boenning & Scattergood
Boenning & Scattergood analyst Merrill Ross initiated Tanger Factory with an Outperform and $27 price target.
05/09/19
GSCO
05/09/19
DOWNGRADE
Target $15
GSCO
Sell
Tanger Factory downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Caitlin Burrows downgraded Tanger Factory to Sell from Neutral and lowered her price target for the shares to $15 from $19.80. The analyst does not expect a near-term reacceleration in the company's earnings growth.
MDR McDermott
$1.95

0.2 (11.43%)

10/31/18
KEYB
10/31/18
DOWNGRADE
KEYB
Sector Weight
McDermott downgraded to Sector Weight from Overweight at KeyBanc
09/20/19
FBCO
09/20/19
NO CHANGE
Target $7
FBCO
Neutral
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
Credit Suisse analyst Jamie Cook says McDermott's announcement that it will explore selling its Lummus technology business was considered "a last resort," but was "unfortunately needed" to improve the balance sheet. Cook, who maintains a Neutral rating and $7.00 price target, says she believes McDermott would prefer to retain some ownership in order to retain rights to be the first bidder on the EPC business if possible. She feels a transaction could occur "quickly," given the asset was already on the market recently and says she believes the stock should rally on this news given the dramatic sell off this week and that management is not considering chapter 11.
09/19/19
SBSH
09/19/19
NO CHANGE
Target $7
SBSH
Neutral
Citi sees working capital unwind as 'legitimate risk' for McDermott
Shares of McDermott dropped 63% yesterday following news that the company hired turnaround firm AlixPartners for "strategic and operational advice." Low liquidity, high leverage, and lingering headwinds associated with legacy CB&I-related projects pose elevated risk for the company, Citi analyst Andrew Kaplowitz tells investors in a research note. The analyst admits that he does not know what's causing McDermott to turn to AlixPartners. He sees a "wide range of possibilities with little visibility to near-term outcomes," which leads to his continued Neutral rating on the shares. McDermott has a "considerable amount of good assets" that are saleable and customers have an incentive to see the company succeed, says Kaplowitz. However, a working capital unwind is now a "legitimate risk" and it may be harder for McDermott to win work at this point, adds the analyst.
09/11/19
SBSH
09/11/19
NO CHANGE
Target $7
SBSH
Neutral
McDermott price target lowered to $7 from $11 at Citi
Citi analyst Andrew Kaplowitz lowered his price target for McDermott to $7 from $11 while keeping a Neutral rating on the shares. While the analyst sees "some light at the end of the tunnel" for the company on its two "troublesome" liquefied natural gas projects and believes the negative estimate revisions for CBI Legacy work may be behind the company, he says he can't rule out "further project-related noise." Further, McDermott's balance sheet is still relatively levered and some uncertainty regarding the timing of asset sales remains, Kaplowitz tells investors in a research note.
NIO NIO Inc.
$1.53

-0.105 (-6.44%)

09/26/19
WOLF
09/26/19
DOWNGRADE
Target $1.9
WOLF
Peer Perform
NIO Inc. downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Dan Galves downgraded NIO Inc. to Peer Perform from Outperform, stating that the company's cash burn was worse than expected in Q2 and its volume and margin guidance was "disappointing." The company's financing outlook has become "completely unclear" and the lack of a financing announcement along with earnings is "concerning," said the analyst, who set a $1.90 price target on the stock.
10/04/19
10/04/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Inc. (HPQ) downgraded to Hold from Buy at Loop Capital with analyst Ananda Baruah citing HP's Analyst Day presentation disclosing strategic initiatives, job cuts, and a free cash flow guide of $3B in FY20 vs. $3.7B in FY21. 2. Insulet (PODD) downgraded to Neutral from Buy at UBS with analyst Matthew Taylor citing valuation. 3. NIO Inc. (NIO) downgraded to Neutral from Buy at Goldman Sachs with analyst Fei Fang saying Nio's share price has fallen 40% since September 24, when the company announced Q2 results, which Fang attributes to uncertainties about volume since Chinese EV sales have rapidly declined after the government reduced electric vehicle subsidies and about the company's capital structure and funding needs. 4. EchoStar (SATS) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying the company's lack of free cash flow and limited visibility on its future growth prospects will likely limit the potential for multiple expansion. 5. Ambarella (AMBA) resumed with a Hold from Buy at Stifel with analyst Tore Svanberg saying he believes inventory build in security surveillance, especially China, could limit near term upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/19
GSCO
10/04/19
DOWNGRADE
GSCO
Neutral
NIO Inc. downgraded to Neutral from Buy at Goldman Sachs
10/04/19
GSCO
10/04/19
DOWNGRADE
Target $1.47
GSCO
Neutral
Goldman Sachs downgrades NIO Inc. to Neutral, slashes target to $1.47 from $9.76
Goldman Sachs analyst Fei Fang downgraded NIO Inc. to Neutral from Buy with a price target of $1.47, down from $9.76. Nio's share price has fallen 40% since September 24, when the company announced Q2 results, which Fang attributes to uncertainties about volume since Chinese EV sales have rapidly declined after the government reduced electric vehicle subsidies and about the company's capital structure and funding needs. Fang maintains a 2023 estimate of the total addressable market for EVs in China of 1M new car sales, but lowered Nio's 2023 market share forecast to 15% from 25% due to more intense EV competition.
USO United States Oil Fund
$11.20

0.215 (1.96%)

CRC California Resources
$8.54

0.17 (2.03%)

04/12/19
GSCO
04/12/19
NO CHANGE
GSCO
Goldman downgrades California Resources, Chesapeake to Sell, upgrades Murphy
Within the Exploration and Production space, Goldman Sachs analyst Brian Singer recommends selling stocks where the valuation post recent rallies "appears at odds" with the company's competitive positioning. With that in mind, Singer downgraded both California Resources (CRC) and Chesapeake Energy (CHK) to Sell from Neutral. California Resources has a low decline rate and competitive supply cost but unfavorable debt cost that does not warrant the extent of its current valuation premium, says the analyst. For Chesapeake, Singer sees less favorable supply cost and corporate returns. The analyst also upgraded Murphy Oil (MUR) to Neutral from Sell. He believes the stock's current valuation appears more in line with its competitive positioning. Singer recommends buying "low cost oil suppliers" Encana (ECA), Parsley Energy (PE), Pioneer Natural (PXD) and EOG Resources (EOG) and Chevron (CVX).
05/13/19
05/13/19
UPGRADE
Target $30

Outperform
California Resources upgraded to Outperform on valuation at Raymond James
As previously reported, Raymond James upgraded California Resources to Outperform from Market Perform and $30 price target. Analyst Pavel Molchanov said regulatory fears are "overdone" and the sell-off in shares has created a "beaten-down" valuation.
08/05/19
IMPC
08/05/19
NO CHANGE
Target $20
IMPC
Outperform
California Resources price target lowered to $20 from $28 at Imperial Capital
Imperial Capital analyst Jason Wangler lowered his price target for California Resources to $20 from $28 saying the company's Q2 results were impacted by lower natural gas liquid prices. However, California Resources was able to remain near cash flow positive, adds the analyst, who keeps an Outperform rating on the shares.
05/13/19
RAJA
05/13/19
UPGRADE
RAJA
Outperform
California Resources upgraded to Outperform at Raymond James
ICPT Intercept
$58.92

1.55 (2.70%)

08/08/19
OPCO
08/08/19
NO CHANGE
Target $150
OPCO
Outperform
Intercept price target lowered to $150 from $160 at Oppenheimer
Oppenheimer analyst Jay Olson lowered his price target for Intercept (ICPT) to $150 from $160, while reiterating an Outperform rating on the shares following quarterly results. The analyst recognizes the PBC business faces challenges including the potential for price erosion assuming OCA becomes available for NASH at a higher dose and lower price and multiple competitive entries including CymaBay's (CBAY) seladelpar, which is also being studied for NASH. Olson also believes recent competitor studies in NASH increase the scarcity value of Intercept's registrational asset, and thinks MRI-PDFF results for seladelpar have no impact on Intercept's plans to study a combination of OCA plus bezafibrate in NASH. Additionally, he considers the Q3 regulatory submission for OCA in NASH as a positive catalyst if granted a priority review.
09/04/19
09/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Campbell Soup (CPB) upgraded to Neutral from Underweight at Piper Jaffray with analyst Michael Lavery saying better focus and reinvestment in key brands can drive long-term benefits for Campbell. 2. Intercept (ICPT) upgraded to Buy from Neutral at Citi with analyst Joel Beatty saying the stock is down 45% since the Phase 3 nonalcoholic steatohepatitis Regnerate results for Intercept's obeticholic acid were announced in February, despite the data being positive. 3. Brunswick (BC) upgraded to Buy from Hold at Jefferies with analyst Randal Konik saying with expectations recalibrated post the Q2 results, Brunswick's risk/reward set-up is at its most favorable in four years. 4. Stamps.com (STMP) upgraded to Neutral from Sell at Roth Capital with analyst Darren Aftahi saying after a round of channel checks with United State Postal Service ecosystem participants, the analyst believes more favorable rate cards for resellers could continue into 2020. As a result, he has a slightly more favorable view of Stamps.com's 2020, with raised revenue and adjusted EBITDA estimates. 5. Activision Blizzard (ATVI) upgraded to Outperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying he has a stronger conviction that the company's restructuring efforts and its investment in core franchise titles like Call of Duty and World of Warcraft will yield improved financial performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/19
SBSH
09/04/19
UPGRADE
Target $85
SBSH
Buy
Intercept upgraded to Buy from Neutral at Citi
Citi analyst Joel Beatty upgraded Intercept Pharmaceuticals to Buy from Neutral while lowering his price target for the shares to $85 from $106.
09/04/19
SBSH
09/04/19
UPGRADE
Target $85
SBSH
Buy
Citi upgrades Intercept to Buy amid 'more realistic' NASH expectations
Citi analyst Joel Beatty upgraded Intercept Pharmaceuticals to Buy from Neutral while lowering his price target for the shares to $85 from $106. The stock is down 45% since the Phase 3 nonalcoholic steatohepatitis Regnerate results for Intercept's obeticholic acid were announced in February, despite the data being positive, Beatty tells investors in a research note. The analyst believes the selloff is largely due to Street expectations for the launch trajectory of NASH drugs becoming more conservative. Street sentiment around the launch of NASH drugs is now "more realistic," creating an attractive entry point into Intercept shares, says Beatty. He views the U.S. new drug application filing for NASH in Q3 as among the catalysts for Intercept shares.

TODAY'S FREE FLY STORIES

STLD

Steel Dynamics

$29.64

(0.00%)

, IGT

International Game

$14.02

(0.00%)

09:40
10/15/19
10/15
09:40
10/15/19
09:40
Options
Unusually active option classes on open October 15th »

Unusual total active…

STLD

Steel Dynamics

$29.64

(0.00%)

IGT

International Game

$14.02

(0.00%)

JPM

JPMorgan

$116.39

(0.00%)

UNH

UnitedHealth

$220.32

(0.00%)

GS

Goldman Sachs

$205.81

(0.00%)

NVDA

Nvidia

$186.51

(0.00%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.83

(0.00%)

C

Citi

$70.28

(0.00%)

WLL

Whiting Petroleum

$7.26

(0.00%)

SCHW

Charles Schwab

$37.74

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 17

    Oct

  • 18

    Oct

  • 27

    Oct

  • 04

    Nov

  • 06

    Nov

  • 12

    Nov

  • 20

    Nov

CPIX

Cumberland

$5.59

-0.05 (-0.89%)

09:38
10/15/19
10/15
09:38
10/15/19
09:38
Hot Stocks
Cumberland: Study shows Vibativ superiority in some bacterial pneumonia patients »

Cumberland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$67.21

0.16 (0.24%)

09:37
10/15/19
10/15
09:37
10/15/19
09:37
Periodicals
Breaking Periodicals news story on Emerson »

D.E. Shaw to call for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

IAC

IAC

$226.69

-0.5 (-0.22%)

, MTCH

Match Group

$74.00

-0.12 (-0.16%)

09:34
10/15/19
10/15
09:34
10/15/19
09:34
Conference/Events
Cowen US internet/media analyst to hold analyst/industry conference call »

U.S. Internet & Media…

IAC

IAC

$226.69

-0.5 (-0.22%)

MTCH

Match Group

$74.00

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.28

-0.14 (-3.17%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Encana rating change  »

Encana downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

WLL

Whiting Petroleum

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

OAS

Oasis Petroleum

$3.11

-0.135 (-4.17%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$20.44

-0.15 (-0.73%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Upgrade
Noble Energy rating change  »

Noble Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PH

Parker-Hannifin

$178.45

-1.25 (-0.70%)

09:30
10/15/19
10/15
09:30
10/15/19
09:30
Recommendations
Parker-Hannifin analyst commentary  »

Parker-Hannifin sales,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

WHD

Cactus

$28.03

-0.49 (-1.72%)

, HAL

Halliburton

$18.75

-0.195 (-1.03%)

09:30
10/15/19
10/15
09:30
10/15/19
09:30
Recommendations
Cactus, Halliburton, National Oilwell, Newpark Resources, Nine Energy Services, Oil States, Patterson-UTI, Unit Corp., USA Compression analyst commentary  »

Raymond James sees…

WHD

Cactus

$28.03

-0.49 (-1.72%)

HAL

Halliburton

$18.75

-0.195 (-1.03%)

NOV

National Oilwell

$21.10

-0.08 (-0.38%)

NR

Newpark Resources

$6.93

-0.655 (-8.64%)

NINE

Nine Energy Services

$5.16

-0.24 (-4.44%)

OIS

Oil States

$12.93

-0.065 (-0.50%)

PTEN

Patterson-UTI

$8.15

-0.1 (-1.21%)

UNT

Unit Corp.

$2.83

-0.165 (-5.52%)

USAC

USA Compression

$17.40

0.225 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 29

    Oct

  • 31

    Oct

  • 11

    Nov

  • 13

    Nov

JNJ

Johnson & Johnson

$130.67

-0.68 (-0.52%)

09:28
10/15/19
10/15
09:28
10/15/19
09:28
Hot Stocks
Johnson & Johnson says will continue to consider 'opportunistic acquisitions' »

Says: Q3 was a good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

IMO

Imperial Oil

$24.25

-0.235 (-0.96%)

09:27
10/15/19
10/15
09:27
10/15/19
09:27
Upgrade
Imperial Oil rating change  »

Imperial Oil upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDFC

WD-40

$181.18

-2.86 (-1.55%)

09:26
10/15/19
10/15
09:26
10/15/19
09:26
Recommendations
WD-40 analyst commentary  »

WD-40 sets up favorably…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NMIH

NMI Holdings

$26.95

0.01 (0.04%)

09:26
10/15/19
10/15
09:26
10/15/19
09:26
Upgrade
NMI Holdings rating change  »

B. Riley FBR upgrades NMI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KSU

Kansas City Southern

$132.02

-1.5 (-1.12%)

, SAIA

Saia

$96.04

0.48 (0.50%)

09:26
10/15/19
10/15
09:26
10/15/19
09:26
Recommendations
Kansas City Southern, Saia, Union Pacific analyst commentary  »

Truck pricing, volume…

KSU

Kansas City Southern

$132.02

-1.5 (-1.12%)

SAIA

Saia

$96.04

0.48 (0.50%)

UNP

Union Pacific

$159.55

-1.82 (-1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 30

    Oct

  • 13

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

PSTV

Plus Therapeutics

$2.47

0.15 (6.47%)

09:24
10/15/19
10/15
09:24
10/15/19
09:24
Hot Stocks
Plus Therapeutics receives $4.6M reimbursement payment »

Plus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$36.05

-0.065 (-0.18%)

09:23
10/15/19
10/15
09:23
10/15/19
09:23
Earnings
Breaking Earnings news story on Knight-Swift »

Knight-Swift sees Q1 adj.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GNUS

Genius Brands

$0.83

0.0597 (7.75%)

, BABA

Alibaba

$171.22

-1.745 (-1.01%)

09:23
10/15/19
10/15
09:23
10/15/19
09:23
Hot Stocks
Genius Brands CEO says 'more bullish than ever' on future of the company »

Genius Brands…

GNUS

Genius Brands

$0.83

0.0597 (7.75%)

BABA

Alibaba

$171.22

-1.745 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KNX

Knight-Swift

$36.05

-0.065 (-0.18%)

09:23
10/15/19
10/15
09:23
10/15/19
09:23
Earnings
Knight-Swift cuts Q4 adj. EPS view to 62c-65c from 73c-77c, consensus 71c »

The updates to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

FDX

FedEx

$146.81

1.29 (0.89%)

09:22
10/15/19
10/15
09:22
10/15/19
09:22
Hot Stocks
FedEx announces expansion of FedEx Freight Direct »

FedEx Freight, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 17

    Dec

KNX

Knight-Swift

$36.05

-0.065 (-0.18%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20
Earnings
Breaking Earnings news story on Knight-Swift »

Knight-Swift cuts Q3 adj.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$119.05

-2.55 (-2.10%)

, AAPL

Apple

$235.87

-0.34 (-0.14%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20
Hot Stocks
Apple TV app, Apple TV+ coming to Roku platform »

Roku (ROKU) announced the…

ROKU

Roku

$119.05

-2.55 (-2.10%)

AAPL

Apple

$235.87

-0.34 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Nov

ABEO

Abeona Therapeutics

$2.18

-0.05 (-2.24%)

09:19
10/15/19
10/15
09:19
10/15/19
09:19
Hot Stocks
Abeona announces publication of long-term data from Phase 1/2a trial of EB-101 »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTEK

Tetra Tech

$84.87

-0.735 (-0.86%)

09:18
10/15/19
10/15
09:18
10/15/19
09:18
Hot Stocks
Tetra Tech awarded $85M DFID contract for LINKS program in Nigeria »

Tetra Tech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.